Nightmare Recurrence in Patients with Post-traumatic Stress Disorder is Likely a Primary Feature of Central Sympathetic Nervous Activation
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Morgenthaler T, Auerbach S, Casey K, Kristo D, Maganti R, Ramar K
. Position Paper for the Treatment of Nightmare Disorder in Adults: An American Academy of Sleep Medicine Position Paper. J Clin Sleep Med. 2018; 14(6):1041-1055.
PMC: 5991964.
DOI: 10.5664/jcsm.7178.
View
2.
Gupta M
. Spontaneous reporting of onset of disturbing dreams and nightmares related to early life traumatic experiences during the COVID-19 pandemic by patients with posttraumatic stress disorder in remission. J Clin Sleep Med. 2020; 16(8):1419-1420.
PMC: 7446081.
DOI: 10.5664/jcsm.8562.
View
3.
Sierro C, Leslie W, Putois B
. Long-term effects of treatment for chronic nightmares: is imagery rehearsal therapy robust in the COVID-19 pandemic?. J Clin Sleep Med. 2020; 16(11):1993.
PMC: 8034210.
DOI: 10.5664/jcsm.8742.
View